BIONCaRT GmbH
PrivateLast Round
Seed
Aug 21, 2024
Total Funding Raised
$1.21M
Company Overview
BIONCaRT GmbH is a biotechnology company that develops allogeneic, stem cell-based medicines for the treatment of orthopedic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIONCaRT GmbH Comparables
Compare BIONCaRT GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FamiCord AG | 78% | |
| ReLive Biotechnologies | 77% | |
| MEDIPOST Co., Ltd. | 77% | |
BIONCaRT GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 21, 2024 |
BIONCaRT GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| bm|t beteiligungsmanagement thüringen | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 2012% MoM, from 25 to 528.
- Aug 21, 2024
$1.21M round led by bm|t beteiligungsmanagement thüringen.
BIONCaRT GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BIONCaRT GmbH's valuation, stock price, and market status.